1. Home
  2. IIF vs EMBC Comparison

IIF vs EMBC Comparison

Compare IIF & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley India Investment Fund Inc.

IIF

Morgan Stanley India Investment Fund Inc.

HOLD

Current Price

$22.30

Market Cap

206.3M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

BUY

Current Price

$3.13

Market Cap

200.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
IIF
EMBC
Founded
1993
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.3M
200.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
IIF
EMBC
Price
$22.30
$3.13
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
35.4K
2.1M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
13.94%
6.88%
EPS Growth
N/A
20.90
EPS
N/A
0.67
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.64
Revenue Growth
N/A
N/A
52 Week Low
$19.83
$2.77
52 Week High
$28.37
$15.55

Technical Indicators

Market Signals
Indicator
IIF
EMBC
Relative Strength Index (RSI) 59.45 27.72
Support Level $21.75 $3.02
Resistance Level $22.46 $3.48
Average True Range (ATR) 0.41 0.17
MACD 0.13 0.15
Stochastic Oscillator 69.61 17.31

Price Performance

Historical Comparison
IIF
EMBC

About IIF Morgan Stanley India Investment Fund Inc.

Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: